Join the Oncology Voice Network. Join for Free
Field MSL Leadership Panel - MSL QA Session PART TWO with Vanessa Jacobsen, Amy Misnik, and Sue Watson
Medical Science Liaison MSL transition Key Opinion Leaders MSL resume keywords MSL virtual introductions

Field MSL Leadership Panel - MSL QA Session PART TWO with Vanessa Jacobsen, Amy Misnik, and Sue Watson


Share This Article


Summary

In this episode, Tom Caravela is joined by Amy Misnick, Vanessa Jacobson, and Sue Watson to explore a range of topics crucial for current and aspiring Medical Science Liaisons. The discussion covers the transition into the MSL role, including necessary certifications and experiences, and how to craft an effective resume using the right keywords. They also address the impact of the pandemic on MSL performance and the importance of virtual introductions to Key Opinion Leaders (KOLs). The speakers offer insights on demonstrating MSL value within organizations, overcoming experience barriers, and the criteria for ending KOL relationships. They conclude with advice for industry newcomers and a reminder to embrace growth opportunities.

We are part two of our Field MSL Leadership panel, MSL Q&A session with Vanessa Jacobsen, Amy Misnik, and Sue Watson.

In this episode we discuss:

  • What experience or certification can help someone transition into the MSL position
  • How is MSL performance assessed during COVID and the best advice to achieve success
  • What keywords are important to include in the resume
  • Advice for a newly hired MSL during COVID on how to make a lasting impact when introducing themselves to KOLs for the first time virtually
  • How to overcome the job listed requirement of must have prior MSL experience (as an aspiring MSL)
  • How’s training evolving to keep up with the pace of healthcare innovation
  • Showing one’s value internally as an MSL
  • Under what conditions should MSLs discontinue KOL relationship or at what point should an MSL stop trying to connect
  • Advice moving into the rest of COVID and into 2021
  • Advice to younger self

Click for Source
Medical Science Liaison, MSL transition, Key Opinion Leaders, MSL resume keywords, MSL virtual introductions

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology
OVN Avatar Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri

Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Explore OVN